Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy – an observational cross-sectional study

BMC Nephrology201819:375

https://doi.org/10.1186/s12882-018-1149-1

  • Received: 18 November 2018
  • Accepted: 18 November 2018
  • Published:

The original article was published in BMC Nephrology 2018 19:259

Correction to: BMC Nephrol (2018) 19:259 https://doi.org/10.1186/s12882-018-1055-6

Following publication of the original article [1], the authors reported an error in the presentation of Table 3 and Table 4. In this Correction the original and the corrected version of the two tables are given. The original publication of this article has been corrected.

The original presentation of Tables 3 and 4:
Table 3

New

Odds ratio (95% confidence interval)

Multivariate logistic regression with Sarcopenia as dependent variable

 CKD patients (reference)

 

 ESRD-HD

0.31 (0.08, 1.25)

 Renal transplant

0.80 (0.35, 1.83)

 Gender (female =1)

2.87 (1.27, 6.48)

 Age (per year increase)

1.10 (1.06, 1.14)

 Prescribed medications (per no. increase)

1.19 (1.07. 1.32)

 BMI (per unit increase)

0.92 (0.85, 0.99)

Table 4

New

Odds ratio (95% confidence interval)

Multivariate logistic regression with ‘central obesity’ as dependent variable

 CKD patients (reference)

 

 ESRD-HD

2.12 (0.55, 8.18)

 Renal transplant

2.00 (0.71, 5.62)

 Diagnosis of diabetes mellitus

3.10 (1.20, 8.03)

 Fat mass (increase in 1 kg)

1.29 (1.20, 1.39)

The corrected presentation of Table 3 and Table 4:
Table 3

Multivariate logistic regression with Sarcopenia as dependent variable

Odds ratio (95% confidence interval)

 CKD patients (reference)

 

 ESRD-HD

0.31 (0.08, 1.25)

 Renal transplant

0.80 (0.35, 1.83)

 Gender (female =1)

2.87 (1.27, 6.48)

 Age (per year increase)

1.10 (1.06, 1.14)

 Prescribed medications (per no. increase)

1.19 (1.07. 1.32)

 BMI (per unit increase)

0.92 (0.85, 0.99)

Table 4

Multivariate logistic regression with ‘central obesity’ as dependent variable

Odds ratio (95% confidence interval)

 CKD patients (reference)

 

 ESRD-HD

2.12 (0.55, 8.18)

 Renal transplant

2.00 (0.71, 5.62)

 Diagnosis of diabetes mellitus

3.10 (1.20, 8.03)

 Fat mass (increase in 1 kg)

1.29 (1.20, 1.39)

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Clinical Medicine, Center for Nutrition, University of Bergen, Jonas Lies vei 68, 5021 Bergen, Norway
(2)
Department of Nephrology, Haukeland University Hospital, Jonas Lies vei 65, 5021 Bergen, Norway

Reference

  1. Dierkes et al. High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy – an observational cross-sectional study. 2018;19:259. https://doi.org/10.1186/s12882-018-1055-6.

Copyright

© The Author(s). 2018

Advertisement